MONTREAL, March 8 /CNW Telbec/ - Ranaz Corporation (TSXV: RNZ), ("Ranaz"
or the "Corporation") a company specializing in the manufacturing and
marketing of protein and dietary supplements related to weight loss or obesity
treatments, today announced it will distribute its new Protilife products,
intended for the general public, in 327 PJC Jean Coutu franchised drugstores
throughout Ontario, Quebec and New Brunswick.
This represents yet another breakthrough for Ranaz in further widening
its distribution channels. "We're pleased to add Jean Coutu Group (PJC) to our
growing distribution network which will carry our new brand of Protilife
weight-loss products," said Ranaz President and Chief Executive Officer Jean
Bourassa-Marineau. "Our expertise and prominence in the formulation and
continuous development of such effective and tasty products are solid assets.
For 17 years now, we have been manufacturing a full line of products
distributed through specialized channels in Canada, Europe and the United
States. By distributing our products through Jean Coutu Group drugstores, a
major player with considerable marketing expertise, we're accessing a large
distribution network recognized for its commitment to offer consumers quality
products and superior service."
The Protilife product line
The Protilife brand will enable Ranaz to capitalize on its experience in
developing products for the weight loss or obesity treatment industry by
introducing a mass-market product supported by scientific research. The
Corporation wishes to position this brand to eventually establish itself as a
world-class leader in the development and marketing of quality and effective
high-protein weight loss and health supplements and for its consumer market
The Protilife product line aims to enable fast weight loss while
providing the nutrients needed to maintain muscle mass. Once the target
healthy weight is reached, the individual will be able to follow a Protilife
weight maintenance program, which is a diet based on the four food groups, as
recommended by the Canada Food Guide, while integrating Protilife products to
facilitate weight maintenance.
About Ranaz Corporation
Ranaz is a corporation specializing in manufacturing and marketing
protein and dietary supplements in relation to weight loss or obesity
treatments. Its mission is to design, develop and market nutritional, protein
and dietary supplements under private brands, as well as under its own
corporate brands, such as "Protidiet" and "Protilife". Through its
subsidiaries, Ranaz produces high-quality dietary and protein supplements.
Ranaz shares trade under the symbol RNZ on the TSX Venture Exchange since
December 29, 2006.
About Jean Coutu Group (PJC)
The Jean Coutu Group (PJC) Inc. is the fourth largest drugstore chain in
North America and the second largest in both the eastern United States and
Canada. The Company and its combined network of 2,186 corporate and franchised
drugstores (under the banners of Brooks and Eckerd Pharmacy, PJC Jean Coutu,
PJC Clinique and PJC Santé Beauté) employ more than 61,000 people.
The Jean Coutu Group's United States operations employ 46,000 people and
comprise 1,859 corporate owned stores located in 18 states of the
Northeastern, mid-Atlantic and Southeastern United States. The Jean Coutu
Group's Canadian operations and franchised drugstores in its network employ
over 15,000 people and comprise 327 PJC Jean Coutu franchised stores in
Quebec, New Brunswick and Ontario.
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Martin Vidal, Ranaz Corporation, Executive
Vice-President, (450) 491-7106, ext. 213, firstname.lastname@example.org; Jean
Walter, Vice President, MaisonBrison, (514) 731-0000, poste 223,